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Renovascular hypertension is a form of secondary hypertension, and reactive oxygen species play an important role in 
the pathophysiology of hypertension. Here, we tried to evaluate temporal changes in lipid peroxidation and antioxidant 
enzymes activity, in the course of renovascular hypertension. To induce renovascular hypertension, adult male Wistar rats 
were submitted to Goldblatt 2K1C surgery or sham-operated (sham). The blood pressure was directly assessed after 7, 14, 
21 and 28 days. Lipid peroxidation, superoxide dismutase, catalase, glutathione peroxidase (GPx), and glutathione-S-
transferase activities were evaluated in heart and kidneys. Mean blood pressure (mmHg) was higher by 20, 14, 23 and 22% 
(P <0.05), respectively in hypertensive groups 7, 14, 21 and 28 days, than in the control groups (108±7 in 7 days, 101±4 in 
14 days, 109±7 in 21 days and 104±7 in 28 days in sham group; and 130±12 in 7 days, 116±4 in 14 days, 135±16 in 21 days 
and 127±6 in 28 days in hypertensive group). Lipid peroxidation, superoxide dismutase, catalase and glutathione  
S-transferase showed no significant changes. The GPx activity (nmoles.min-1/mg protein) was 47% higher in the hearts 
(90.12±17.63 in sham group and 132.53±12.43 in hypertensive group), 98% in right kidney (66.13±15.10 in sham group and 
131.23±28.32 in hypertensive group), 98% in left kidney of the hypertensive group 7 days in relation to sham group 7 days 
(67.05±17.87 in sham group and 132.87±35.31 in hypertensive group, P <0.05). The main adaptive change promoted by 
hypertension includes an induction of GPx during hypertensive status development. 
Key words: Blood pressure, Goldblatt hypertension, Free radicals, Oxidative stress, ROS 
Hypertension is a common chronic clinical condition
1
, 
and from 1999 to 2016, the estimated absolute burden of 
hypertension among US adults increased
2
. Patients with 
hypertension generally have no clear etiology and are 
classified as having primary hypertension. However, 
some of them may present secondary hypertension, 
which may be caused by renal parenchymal disease, 
hypothyroidism, coarctation of the aorta, renal failure, 
and atherosclerotic renal artery stenosis
3
. 
Human renovascular hypertension, a form of 
secondary hypertension, accounts for 1-2% of all 
cases of hypertension in the general population and 
5.8% of secondary hypertension
4
. Furthermore, 
although reduction of blood flow to the kidneys 
represent less than 10% of the cases of clinical 
hypertension, target-organ injury develops in a pattern 
similar to primary hypertension, and models of 
secondary hypertension might be suitable for 
assessing target-organ injury
5
. 
To study renovascular hypertension, the 
experimental Goldblatt model through partial 
constriction of the renal artery (two-kidney/one clip-
2K1C) is used which increases blood pressure levels 
moderately. In this model, hypertension is developed 
in one week, and blood pressure is persistently 
elevated by several weeks
6
. Interestingly, some 
proteins are transiently increased, like phospho-
extracellular signal-regulated kinase, cell cycle 
inhibitors p21 and p27, and transforming growth 
factor-, which return to baseline levels after five 
weeks
7
. In this context, it is possible that many factors 
present the same transient profile, such as oxidative 
stress markers. 
It has been indicated that reactive oxygen  
species (ROS) play an important role in the 
pathophysiology of hypertension, deriving from 
metabolic processes, which include mitochondrial 
enzymes, uncoupled nitric oxide (NO) synthase (NOS) 
—————— 
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and NADPH oxidase activity in the vascular 
endothelium
8
. In this sense, redox reactions can 
modulate vascular tone and structure, since NO  
could react with superoxide anion (O2
.-
) to form 
peroxynitrite, which itself may cause vasoconstriction 
and increase total peripheral resistance
9
. Such vascular 
alteration can predispose the establishment of 
hypertension, which is associated with increased 
production of superoxide
10
 and hydrogen peroxide
11
, 
while nitric oxide synthesis is decreased
12
. On the order 
hand, the antioxidant defense system plays an important 
role in maintaining blood pressure. As highlight 
antioxidant, the glutathione metabolism seems to  
be relevant and transiently changed on hypertension, 
since newly diagnosed hypertensive patients show 
overexpression of glutathione peroxidase (GPx), as a 
counter regulatory response to the vascular stress
13
, but 
in elderly patients, who often experience hypertension 
for longer, no difference in GPx was observed in relation 
to control group
14
. 
Moderate oxidative stress may lead to adaptive 
responses of antioxidant defenses, in order to 
establish appropriate redox environment in an injury 
situation
15
, but there is a lack of information whether 
a sustained increase in afterload imposed by 
hypertension could lead to renal and cardiac 
adaptations of antioxidant system. According to our 
knowledge, this is the first report in literature showing 
a profile of adaptation in antioxidant enzymes, in the 
course of 2K1C hypertension. Therefore, in this 
study, we evaluated the temporal changes in lipid 
peroxidation and antioxidants enzymes activity, in the 
course of renovascular hypertension. 
 
Materials and Methods 
 
Animals and surgical procedures 
All experimental procedures described in this study 
were conducted according to Brazilian National 
Council for the Control of Animal Experimentation 
(CONCEA) and were approved by the Universidade 
Federal do Rio Grande do Sul (No. 4382000). 
Healthy adult male Wistar rats (250-320 g) were 
purchased from the Central Animal House of  
the Universidade Federal do Rio Grande do Sul (Porto 
Alegre, Brazil). Animals were maintained under 
standard conditions, housed in plastic cages  
(five animals each) and having free access to  
water and pelleted food. They were maintained  
under standard laboratory conditions (controlled 
temperature of 21ºC, 12 h light/dark cycle). 
To induce renovascular hypertension, the classical 
technique of Goldblatt was followed. Rats were 
anesthetized with ketamine hydrochloride (90 mg/kg 
i.p.) and xylazine (10 mg/kg i.p.). Renovascular 
hypertension (2K1C) was induced by a silver clip 
with a 300 m gap width placed around the left renal 
artery. Sham-operated rats (sham) underwent the 
same surgical intervention, without clipping
16
. 
Eighty animals were included in the study, and 
according to the surgical treatment, animals were 
previously randomly divided in eight experimental 
groups: 7, 14, 21 and 28 days after the surgery: 1) sham 
7 days (n=10); 2) hypertensive 7 days (n=10); 3) sham 
14 days (n=10); 4) hypertensive 14 days (n=10); 5) sham 
21 days (n=10); 6) hypertensive 21 days (n=10); 7) sham 
28 days (n=10); 8) hypertensive 28 days (n=10). 
However, the mortality rate, consequent from 
procedures of renovascular hypertension induction and 
arterial catheterization, was 25%. Therefore, the 
remaining sixty animals were as follows: 1) sham 7 days 
(n=7); 2) hypertensive 7 days (n=9); 3) sham 14 days 
(n=6); 4) hypertensive 14 days (n=7); 5) sham 21 days 
(n=6); 6) hypertensive 21 days (n=9); 7) sham 28 days 
(n=7); 8) hypertensive 28 days (n=9). 
 
Hemodynamic measurements 
After 7, 14, 21 and 28 days, and 24 hours before 
the blood pressure measurement, one catheter filled 
with 0.06 mL saline was implanted, under ketamine 
(90 mg/kg i.p.) and xylazine (10 mg/kg i.p.) 
anesthesia, into the carotid artery (PE-50) for  
direct measurement of blood pressure. The arterial 
catheter was connected to a strain gauge transducer 
(P23Db, Gould-Statham, Oxford, CA, USA), and 
blood pressure signals were recorded during a 15 min 
period equipped with an analog-to-digital converter 
board connected to a microcomputer (CODAS, 2 kHz 
sampling frequency, Dataq Instruments, Inc). The 
recorded data were analyzed on a beat-to-beat basis to 
obtain averaged blood pressure and heart rate
17
. 
 
Tissue preparation 
After hemodynamic measurements, animals were 
killed by cervical dislocation, their kidneys and hearts 
were excised and homogenized in 1.15% KCl at  
0-4ºC, in an Ultraturrax tissue blender. The 
suspension was centrifuged at 1000 ×g for 10 min  
at 0-4ºC to remove the nuclei and cell debris
18
.  
The supernatant was collected to determine 
antioxidant enzyme activities and lipid peroxidation 
measurement. 
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Protein measurement 
Protein was measured following Lowry et al.
19
 
with bovine serum albumin as standard. 
 
Lipid peroxidation assay 
Lipid peroxidation was measured trough the 
thiobarbituric acid reactive substances assay, 
according the method described by Buege & Aust
20
. 
Commercially available malondialdehyde was used as a 
standard. Results were expressed as moles/mg protein. 
 
Antioxidant enzyme activities 
Superoxide dismutase (SOD) activity, expressed as 
units/mg protein, was based on the inhibition of 
superoxide radical reaction with pyrogallol
21
. Catalase 
activity was determined by following the decrease in 
240 nm absorption of hydrogen peroxide (H2O2). The 
results were expressed in nmoles of hydrogen 
peroxide reduced.min
-1
/mg protein
22
. Glutathione 
peroxidase (GPx) activity was measured following 
NADPH oxidation at 340 nm. The activity of 
glutathione peroxidase was expressed in nmoles. 
min
-1
/mg protein
23
. Glutathione- S-transferase (GST) 
activity was measured following the formation of 
dinitro-phenil-glutathione, at 340 nm. The activity  
of glutathione transferase was expressed in nmoles. 
min
-1
/mg protein
24
. 
 
Statistical analysis 
Data were analyzed using GraphPad Prism 5.0, and 
reported as mean ± standard error, after Kolmogorov–
Smirnov test for normality. As demanded in each 
case, data were analyzed by one way ANOVA with 
Student-Newmann-Keuls post hoc test. P values of at 
least 0.05 were considered significant. 
 
Results 
No significant changes in heart rate values (bpm) 
were apparent among groups [364±52 (7 days), 
341±35 (14 days), 375±51 (21 days) and 354±38 (28 
days) in sham group and 340±38 (7 days), 327±23 (14 
days), 373±42 (21 days) and 345±45 (28 days) in 
hypertensive group]. 
Mean blood pressure measured in hypertensive 
group was 20% higher than in sham group 7 days, 
14% than in sham group 14 days, 23% than in sham 
group 21 days, and 22% higher than sham group  
28 days (P <0.05) [absolute values: 108±7 (7 days), 
101±4 (14 days), 109±7 (21 days) and 104±7  
(28 days) in sham group and 130±12 (7 days), 116±4 
(14 days), 135±16 (21 days) and 127±6  
(28 days) in hypertensive group] (Fig. 1). 
Content of TBA-RS, SOD, GST and catalase 
activity showed no significant changes in the 
homogenates of hearts, right kidneys and left kidneys 
among groups. Activity of GPx (nmoles/minute per 
miligrama of protein) was 47% higher in hearts 
(90.12±17.63 in sham group and 132.53±12.43 in 
hypertensive group), 98% in right kidney 
(66.13±15.10 in sham group and 131.23±28.32 in 
hypertensive group), 98% in left kidney of the 
hypertensive group 7 days in relation to sham group  
7 days (67.05±17.87 in sham group and 132.87±35.31 
in hypertensive group, P <0.05) (Table 1). 
 
Discussion 
This is the first study to characterize the oxidative 
profile of renovascular hypertension in rat’s kidneys 
and hearts. Besides no changes in catalase, SOD and 
GST, GPx shows a transient elevation, suggesting an 
adaptation in antioxidant status. 
There are a lot of models to study hypertension, 
such as excessive salt intake, genetic predisposition, 
as observed in spontaneously hypertensive rat, and 
drug induction. Meanwhile, renovascular hypertension 
model is extremely interesting, in which renin-
angiotensin-aldosterone (RAS) system plays a pivotal 
role
6
. Angiotensin II represents the major vasoactive 
peptide derived by a RAS activation which might be 
involved in the production of mitochondrial ROS
25
. In 
this model, seven days after surgery resulted in 
increased blood pressure, and the plateau was 
sustained in the following weeks. Rizzi et al.
26
 
showed high pressure in 15 days, with an increasing 
in 30 and 75 days. Furthermore, about 20% of the 
 
 
Fig. 1 — Mean blood pressure. [Data expressed as mean ± standard 
error of mean. * Represents significant difference compared to 
respective control group at the same time point (P <0.05)] 
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animals did not develop hypertension, results that are 
in agreement with literature data
27
. Animals that did 
not develop hypertension were with normal-
appearance left kidney. They did not reach high 
pressure values probably due to small renal artery 
stenosis, which was not sufficient to trigger 
hypertension, due to contralateral compensation. 
Some animals, about 5%, presented left kidney 
atrophied. However, these animals had hypertension, 
showing that blood flow to the kidney was not 
blocked, only decreased. 
In relation to oxidative stress, there were no 
changes in lipid peroxidation of hypertensive animals 
compared to controls. Some studies showed increased 
ROS production in contralateral kidney
28
, such as 
increased lipid peroxidation in plasma of Goldblatt 
2K1C hypertensive rats
29
 and hypertensive animal 
organs treated with L-NAME, an inhibitor of nitric 
oxide synthesis
30
. These different results could be due 
to the moderate blood pressure levels found in the 
present work. The values of blood pressure found in 
hypertensive animals in this study are similar to those 
found in previous data from our group, in which 
hypertensive 2K1C females did not change lipid 
peroxidation
17
. Similar results were also found in 
stress-sensitive hypertensive ISIAH rats
31
. In addition, 
when hypertension is induced with L-NAME, it may 
cause myocardial ischemic injury and especially 
necrotic foci, which can be related to free radicals
32
. It 
has been reported that Goldblatt model induces 
development of left ventricular hypertrophy, but do 
not ischemic lesions
26
. Since the lesions may be 
related to free radicals, and this model does not show 
these lesions, the results are in accordance. 
In relation to antioxidant enzyme activity, there 
was a pronounced increase in GPx activity with seven 
days of hypertension. Increased activity of GPx was 
observed in rat hearts using the model of hypertension 
by inhibiting synthesis of nitric oxide
30
 and in human 
plasma of essential hypertension
33
. Glutathione (GSH) 
levels are reduced after 7 days
34
 and 9 days
35
 of 2K1C 
hypertension in rats, with is in accordance to the 
increase in GPx activity, since this enzyme expend 
GSH. However, six weeks after clipping there is no 
difference in the erythrocyte GSH levels among 
control and hypertensive groups
36
. These results 
suggest an increased production of lipid peroxides 
before seven days of hypertension, the main substrate 
for this enzyme. This elevated enzyme activity could 
contribute to the maintenance of lipid peroxidation 
products in similar levels to control at this stage. The 
remarkable increase in GPx activity against a 
variation in blood pressure could also prepare the 
tissues to sustained high pressure in the subsequent 
phases (14, 21 and 28 days). 
The enzymes SOD, catalase and GST did not 
change significantly at different time points. In a 
previous study, human serum SOD level showed no 
difference
37
, but catalase activity was decreased in a 
study in a hypertension model by aortic stenosis, in 
Table 1 — Oxidative stress biomarkers: lipoperoxidation and antioxidant enzymes 
 Sham  Hypertensive 
 7 days 14 days 21 days 28 days  7 days 14 days 21 days 28 days 
Heart          
TBARS 0.62±0.21 0.74±0.12 1.61±0.46 0.68±0.14  1.2±0.35 0.62±0.34 1.43±0.38 0.58±0.11 
CAT activity 4.46±0.43 3.60±0.26 3.28±0.38 3.17±0.28  4.26±0.62 3.30±0.18 4.74±0.89 2.64±0.16 
GPx activity 90.12±17.63 49.65±1.58 90.57±21.32 60.76±4.86  132.53±12.43* 53.16±2.51 87.63±24.89 61.53±9.90 
GST activity 1.62±0.42 0.75±0.16 1.52±0.22 1.09±0.10  1.31±0.13 0.78±0.12 1.60±0.19 1.03±0.16 
SOD activity 14.41±2.54 12.32±1.41 12.08±0.84 16.66±0.92  14.09±1.38 11.69±1.80 15.83±1.51 11.50±1.13 
Right kidney          
TBARS 0.82±0.26 2.13±0.29 1.65±0.73 1.44±0.11  0.96±0.23 1.06±0.12 1.66±0.37 1.95±0.16 
CAT activity 9.66±0.76 7.80±0.73 8.32±2.27 8.54±0.44  9.93±0.72 7.62±0.51 11.90±1.29 7.99±0.48 
GPx activity 66.13±15.10 36.72±4.62 74.16±15.68 39.47±3.02  131.23±28.32* 44.66±6.12 73.20±18.66 42,57±3.96 
GST activity 2.66±0.26 1.87±0.26 3.07±0.98 3.22±0.28  3.04±0.53 2.41±0.11 3.37±0.32 2.61±0.44 
SOD activity 12.16±0.80 11.41±0.66 9.09±2.08 11.97±0.28  9.78±0.66 10.03±1.11 13.21±0.99 10.12±0.30 
Left kidney          
TBARS 1.05±0.34 1.29±0.21 1.4±0.62 1.31±0.11  1.04±0.23 0.53±0.12 1.42±0.30 1.31±0.26 
CAT activity 10.50±1.10 8.68±0.65 9.28±2.29 8.23±0.75  9.31±0.58 9.32±0.78 10.15±0.26 6.85±0.85 
GPx activity 67.05±17.87 38.99±4.51 82.24±16.76 61.32±20.92  132.87±35.31* 36.26±2.38 60.91±7.76 33.58±4.26 
GST activity 2.49±0.36 2.13±0.27 3.01±0.81 3.02±0.33  2.70±0.44 2.04±0.39 2.59±0.13 2.46±0.60 
SOD activity 11.34±0.71 10.44±0.96 8.08±0.87 11.64±0.51  10.6±0.87 8.84±1.50 12.74±1.32 12.18±1.67 
[TBARS: thiobarbituric acid reactive substances (µmol/mg prot); CAT: Catalase (nmol/mg prot); GPx: glutathione peroxidase 
(nmol/min/mg prot); GST: glutathione transferase (nmol/min/mg prot); SOD: superoxide dismutase (U SOD/mg prot). Data expressed as 
mean ± standard error. *P ≤0.05] 
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which the pressure levels were higher (162 mm Hg) 
than we found
38
, and was also decreased in cardiac 
tissue after 12 weeks in rats underwent a renovascular 
surgery, when compared to control rats
39
. Studies 
showed that renovascular hypertension enhanced 
superoxide anion generation in the thoracic aortas
40
 
and in carotid arteries
41
 from 2K1C rats after  
8 weeks of surgery, which could increase SOD 
activity. It is possible that in our study the early 
increase of GPx was enough to protect tissues against 
oxidative stress. 
The major limitation of our study is that we only 
accessed the periods of 7, 14, 21 and 28 days, and the 
transient changes could be seen in different time 
points. In addition, we carried out measurements of 
activity of antioxidant enzymes, not expression. 
Otherwise, clinical insights offered by a study 
performed with animals are limited. 
 
Conclusion 
The observations in this study suggest that main 
adaptive changes promoted by hypertension include 
an induction of GPx during hypertensive status 
development. Temporal change evaluation of 
oxidative stress, related to the increased blood 
pressure, is relevant in order to understand the best 
ways to preventing and treating this risk factor for 
cardiovascular diseases. 
 
Acknowledgment 
We are grateful to Tânia Regina Gattelli for technical 
assistance. This work was supported by Brazilian 
Federal Agency for Support and Evaluation of 
Postgraduate Education (CAPES) and National Council 
for Scientific and Technological Development (CNPq). 
 
Conflict of interest 
The authors report no conflict of interest.  
 
References 
1 Buford TW, Hypertension and aging. Ageing Res Rev, 26 
(2016) 96. 
2 Dorans KS, Mills KT, Liu Y & He J, Trends in Prevalence 
and Control of Hypertension According to the 2017 
American College of Cardiology/American Heart Association 
(ACC/AHA) Guideline. J Am Heart Assoc, 7 (2018) 
E008888. 
3 Charles L, Triscott J & Dobbs B, Secondary Hypertension: 
Discovering the Underlying Cause. Am Fam Physician, 96 
(2017) 453. 
4 Samadian F, Dalili N & Jamalian A, New Insights Into 
Pathophysiology, Diagnosis, and Treatment of Renovascular 
Hypertension. Iran J Kidney Dis, 11 (2017) 79. 
5 Lerman LO, Kurtz TW, Touyz RM, Ellison DH, Chade AR, 
Crowley SD, Mattson DL, Mullins JJ, Osborn J, Eirin A, 
Reckelhoff JF, Iadecola C, Coffman TM, Animal Models of 
Hypertension: A Scientific Statement From the American 
Heart Association. Hypertension, 73 (2019) e87. 
6 Leong XF, Ng CY & Jaarin K, Animal Models in 
Cardiovascular Research: Hypertension and Atherosclerosis. 
Biomed Res Int, 2015 (2015) 528757. 
7 Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, 
Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath 
KA & Grande JP, Temporal analysis of signaling pathways 
activated in a murine model of two-kidney, one-clip 
hypertension. Am J Physiol Renal Physiol, 297 (2009) 
F1055. 
8 Togliatto G, Lombardo G & Brizzi MF, The Future 
Challenge of Reactive Oxygen Species (ROS) in 
Hypertension: From Bench to Bed Side. Int J Mol Sci, 18 
(2017) E1988. 
9 Schulz E, Gori T & Münzel T, Oxidative stress and 
endothelial dysfunction in hypertension. Hypertens Res, 34 
(2011) 665. 
10 Ago T, Kuroda J, Kamouchi M, Sadoshima J & Kitazono T, 
Pathophysiological roles of NADPH oxidase/nox family 
proteins in the vascular system - Review and perspective. 
Circ J, 75 (2011) 1791. 
11 Massaro M, Scoditti E, Carluccio MA & Caterina R, 
Oxidative stress and vascular stiffness in hypertension: A 
renewed interest for antioxidant therapies? Vascul 
Pharmacol, 19 (2019) S1537. 
12 Török J, Participation of nitric oxide in different models of 
experimental hypertension. Physiol Res, 57 (2008) 813. 
13 Selvaraj N, Sathiyapriya V, Bobby Z, Nandeesha H & 
Aparna A, Elevated glutathione peroxidase in newly 
diagnosed hypertension: its relation to insulin resistance. Clin 
Exp Hypertens, 35 (2013) 195. 
14 Rybka J, Kupczyk D, Kędziora-Kornatowska K, Motyl J, 
Czuczejko J, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, 
Carvalho LA & Kędziora J, Glutathione-related antioxidant 
defense system in elderly patients treated for hypertension. 
Cardiovasc Toxicol, 11 (2011) 1. 
15 Cardoso AM, Bagatini MD, Roth MA, Martins CC,  
Rezer JF, Mello FF, Lopes LF, Morsch VM & Schetinger MR, 
Acute effects of resistance exercise and intermittent intense 
aerobic exercise on blood cell count and oxidative stress in 
trained middle-aged women. Braz J Med Biol Res, 45 (2012) 
1172. 
16 Goldblatt H, Lynch J, & Sumerville W, Studies on 
Experimental Hypertension. I. The Production of Persistent 
Elevation of Systolic Blod Pressure by Means of Renal 
Ischemia. J Exp. Med, 59 (1934) 32. 
17 Barp J, Sartório CL, Campos C, Llesuy SF, Araujo AS & 
Belló-Klein A, Influence of ovariectomy on cardiac oxidative 
stress in a renovascular hypertension model. Can J Physiol 
Pharmacol, 90 (2012) 1229. 
18 Llesuy SF, Milei J, Molina H, Boveris A & Milei S, 
Comparison of lipid peroxidation and myocardial damage 
induced by adriamycin and 4'-epiadriamycin in mice. 
Tumori, 71 (1985) 241. 
19 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ, Protein 
measurement with the Folin phenol reagent. J Biol Chem, 
193 (1951) 265. 
INDIAN J EXP BIOL, JANUARY 2020 
 
 
44 
20 Buege JÁ & Aust SD, Microsomal lipid peroxidation. 
Methods Enzymol, 52 (1978) 302. 
21 Marklund S, Marklund G, Involvement of the superoxide 
anion radical in the autoxidation of pyrogallol and a 
convenient assay for superoxide dismutase. Eur J Biochem, 
47 (1974) 469. 
22 Aebi H, Catalase in vitro. Methods Enzymol, 105 (1984) 121. 
23 Flohé L & Günzler WA. Assays of glutathione peroxidase. 
Methods Enzymol, 105 (1984) 114. 
24 Mannervik B & Guthenberg C, Glutathione transferase 
(human placenta). Methods Enzymol, 77 (1981) 231. 
25 Masi S, Uliana M & Virdis A, Angiotensin II and vascular 
damage in hypertension: Role of oxidative stress and 
sympathetic activation. Vascul Pharmacol, 115 (2019) 13. 
26 Rizzi E, Ceron CS, Guimaraes DA, Prado CM, Rossi MA, 
Gerlach RF & Tanus-Santos JE, Temporal changes in cardiac 
matrix metalloproteinase activity, oxidative stress, and  
TGF-β in renovascular hypertension-induced cardiac 
hypertrophy. Exp Mol Pathol, 94 (2013) 1. 
27 Chelko SP, Schmiedt CW, Lewis TH, Lewis SJ & Robertson TP, 
A novel vascular clip design for the reliable induction of 2-
kidney, 1-clip hypertension in the rat. J Appl Physiol, 112 
(2012) 362. 
28 Nishi EE, Lopes NR, Gomes GN, Perry JC, Sato AYS, 
Naffah-Mazzacoratti MG, Bergamaschi CT & Campos RR, 
Renal denervation reduces sympathetic overactivation, brain 
oxidative stress, and renal injury in rats with renovascular 
hypertension independent of its effects on reducing blood 
pressure. Hypertens Res, 42 (2019) 628. 
29 Gómez GI & Velarde V, Boldine Improves Kidney Damage 
in the Goldblatt 2K1C Model Avoiding the Increase in  
TGF-β. Int J Mol Sci, 19 (2018) E1864. 
30 Bock PM, Araújo A & Belló-Klein A, Enalapril effects on 
nitric oxide synthase inhibition-induced hypertension: 
hemodynamic and oxidative stress evaluations. Lat Am J 
Pharm (former Acta Farmaceutica Bonaerense), 30 (2011) 
913. 
31 Kolesnikova LI, Rychkova LV, Kolesnikova LR, 
Darenskaya MA, Natyaganova LV, Grebenkina LA,  
Korytov LI & Kolesnikov SI, Coupling of Lipoperoxidation 
Reactions with Changes in Arterial Blood Pressure in 
Hypertensive ISIAH Rats under Conditions of Chronic Stress. 
Bull Exp Biol Med, 164 (2018) 712. 
32 Moreno Júnior H, Nathan LP, Metze K, Costa SK, Antunes E, 
Hyslop S, Zatz R & de Nucci G, Non-specific inhibitors of 
nitric oxide synthase cause myocardial necrosis in the rat. 
Clin Exp Pharmacol Physiol, 24 (1997) 349. 
33 Russo C, Olivieri O, Girelli D, Faccini G, Zenari ML, 
Lombardi S & Corrocher R, Anti-oxidant status and lipid 
peroxidation in patients with essential hypertension.  
J Hypertens, 16 (1998) 1267. 
34 Boshra V & Abbas AM, Effects of peripherally and centrally 
applied ghrelin on the oxidative stress induced by renin 
angiotensin system in a rat model of renovascular 
hypertension. J Basic Clin Physiol Pharmacol, 28 (2017) 
347. 
35 Kaur S & Muthuraman A, Therapeutic evaluation of rutin in 
two-kidney one-clip model of renovascular hypertension in 
rat. Life Sci, 150 (2016) 89. 
36 Shimoura CG, Lincevicius GS, Nishi EE, Girardi AC,  
Simon KA, Bergamaschi CT & Campos RR, Increased 
Dietary Salt Changes Baroreceptor Sensitivity and Intrarenal 
Renin-Angiotensin System in Goldblatt Hypertension. Am J 
Hypertens, 30 (2017) 28. 
37 Assadpoor-Piranfar M, Pordal AH & Beyranvand MR, 
Measurement of oxidized low-density lipoprotein and 
superoxide dismutase activity in patients with hypertension. 
Arch Iran Med, 12 (2009) 116. 
38 Polizio AH, Balestrasse KB, Yannarelli GG, Noriega GO, 
Gorzalczany S, Taira C & Tomaro ML, Angiotensin II 
regulates cardiac hypertrophy via oxidative stress but not 
antioxidant enzyme activities in experimental renovascular 
hypertension. Hypertens Res, 31 (2008) 325. 
39 Kumral ZN, Sener G, Ozgur S, Koc M, Suleymanoglu S, 
Hurdag C & Yegen BC, Regular exercise alleviates 
renovascular hypertension-induced cardiac/endothelial 
dysfunction and oxidative injury in rats. J Physiol 
Pharmacol, 67 (2016) 45. 
40 Martins-Oliveira A, Guimaraes DA, Ceron CS, Rizzi E, 
Oliveira DMM, Tirapelli CR, Casarini DE, Fernandes FB, 
Pinheiro LC & Tanus-Santos JE, Direct renin inhibition is 
not enough to prevent reactive oxygen species generation and 
vascular dysfunction in renovascular hypertension. Eur J 
Pharmacol, 821 (2018) 97. 
41 Bunbupha S, Wunpathe C, Maneesai P, Berkban T, 
Kukongviriyapan U, Kukongviriyapan V, Prachaney P & 
Pakdeechote P, Carthamus tinctorius L. extract improves 
hemodynamic and vascular alterations in a rat model of 
renovascular hypertension through Ang II-AT. Ann Anat, 
216 (2018) 82. 
 
